Researchers uncover potential flaws in test for Lyme Disease

June 30, 2016, Taylor & Francis

A new microscopy technique (LM-method) developed to detect Lyme disease is unable to distinguish infected patients from healthy controls, yielding false-positive results that could lead doctors to over-diagnose a patient, according to new research published in the journal Infectious Diseases.

The new research follows up on a previous study suggesting that modified microscopy techniques (LM-method) could detect active cases of Lyme disease (caused by Borrelia bacteria) and Babesia (a tick-borne malaria-like parasite) in just one to two days. Despite considerable publicity and patient demand for this test in Norway, earlier studies did not include a control group and methods were not validated and ready for use in patients.

To investigate the reliability of the new test, Dr Audun Aase, from the Norwegian Institute of Public Health, and his colleagues collected blood samples both from people who had been suffering from Lyme disease-like symptoms for several years and previously tested positive for Borrelia and/or Babesia by the LM-method (21 people), and healthy controls with no known history of tick bites (41 people). The samples were then masked and analyzed in independent laboratories using a range of diagnostic tests including the LM-method, conventional microscopy, genetic fingerprint testing (PCR), and serology.

The results indicate that the new LM-method can trigger false positives, suggesting people have Lyme disease when they really don't. Using the LM-method, 14 (66%) patient group blood samples and 35 (85%) control group samples were judged positive for Borrelia and/or Babesia. However, only one (5%) of the patient group and eight samples (20%) of the tested positive for Borrelia DNA by PCR. None of the samples were positive for Babesia DNA, and conventional microscopy did not identify Babesia in any of the samples.

In an accompanying editorial commentary, Dr Ram B. Dessau, an expert on infectious diseases and Senior Consultant at Slagelse Hospital, Slagelse, Denmark, writes, "I hope the study serves as a warning against non-validated microscopic procedures and helps prevent mismanagement of patients with chronic complaints, who are lured to seek improper diagnosis in the future."

Lyme disease is the most common tick-borne infection in Europe and North America, with 360,000 cases reported over the last 20 years in Europe alone. While most people who contract the Lyme disease recover quickly after antibiotic treatment, up to a fifth of patients report persistent symptoms years after they have been told standard tests are negative for the . Interest in new diagnostic tests is therefore high.

Explore further: Expert warns of new tick-borne disease

More information: Audun Aase et al. Validate or falsify: Lessons learned from a microscopy method claimed to be useful for detectingandorganisms in human blood, Infectious Diseases (2016). DOI: 10.3109/23744235.2016.1144931

Related Stories

Expert warns of new tick-borne disease

June 13, 2016
As spring awakens here in UConn country, so do the ticks. UConn veterinarian, researcher, and tick-borne disease expert Dr. Sandra Bushmich recently answered questions about ticks and the diseases they carry in this area, ...

Researchers identify new Borrelia species that causes Lyme disease

February 8, 2016
Mayo Clinic researchers, in collaboration with the Centers for Disease Control and Prevention (CDC) and health officials from Minnesota, North Dakota and Wisconsin, have discovered a new bacterial species that causes Lyme ...

Lyme disease 'Biofilm' eludes antibiotics: report

February 25, 2016
(HealthDay)—The bacteria that causes Lyme disease protects itself from antibiotics by forming a slime-like layer called a biofilm, a new study shows.

New test for early detection of Lyme disease

April 25, 2016
As part of the EU "ID Lyme" project, the infection immunology working group at the Institute for Hygiene and Applied Immunology at the Center for Pathophysiology, Infectiology and Immunology at the Medical University of Vienna ...

Study shows GMU's Lyme disease early-detection test is effective

May 19, 2016
After three years and 300 patients, George Mason University researchers have proof that their early-detection urine test for Lyme disease works.

Lyme disease testing: Canadians may receive false-positives from some US labs

August 31, 2015
Lyme disease is becoming increasingly common in Canada, and Canadians with Lyme disease symptoms may seek diagnoses from laboratories in the United States, although many of the results will be false-positives, according to ...

Recommended for you

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.